期刊文献+

影响子宫内膜癌复发的高危因素分析 被引量:4

A clinical analysis of endometrial carcinoma
下载PDF
导出
摘要 目的回顾性分析总结影响子宫内膜癌复发的高危因素。方法对2000年12月至2004年12月收治的189例子宫内膜癌病例进行回顾性分析,进一步探讨病理类型、组织学分级、肌层浸润深度、淋巴结转移、手术病理分期、合并症与复发之间的关系。结果手术病理分期,不同病理类型、组织学分级,有无肌层浸润和淋巴结转移中患者的缓解曲线比较,结果均P<0.05,差异有统计学意义;有无合并糖尿病、高血压或肥胖患者的缓解曲线比较,结果均P>0.05,差异无统计学意义。COX回归多因素分析,肌层浸润深度及术后病理类型对复发的影响有统计学差异,P<0.05。结论特殊病理类型、组织学低分化、深肌层浸润、淋巴结转移、期别晚是复发的高危因素。 Objective To analyze high risk factors for prognosis of endometrial carcinoma. Methods To summarize the influence of pathologic type, histologic grade, myometrial invasion depth, lymph node metastasis, surgical-pathologic stage and complications on prognosis of 189 cases with endometrial carcinoma from Dec. 2000 to Dec. 2004. Results The comparisons of the alleviate curves in different surgical-pathologic stages, pathologic types , histologic grades, different depth of myometrial invasion , and wether with lymph nodemetastasis were both P 〈 0. 05, they indicated the differences were statistically significant. The comparisons of the alleviate curves in wether with diabetes, hypertension or fat were both P 〉 0. 05, they were not statistically different. By multivariate analysis, depth of myometrial invasion and special pathologic type were independent high risk factors for the recurrence (P 〈 0. 05). Conclusion Special pathologic types, high histological grade, deep myometrial invasion, lymph node metastasis, late-stages are high risk factors of recurrence.
出处 《中国实用医药》 2009年第25期1-3,共3页 China Practical Medicine
基金 国家自然科学基金(项目编号:30772332) 广东省自然科学基金(项目编号:7001568) 广东省科技计划项目(项目编号:2007B030502014) 广州市科技计划项目(项目编号:2007Z3-E0601)
关键词 子宫内膜癌 高危因素 复发 Endometrial carcinoma High risk factor Recurrence
  • 相关文献

参考文献6

二级参考文献15

  • 1郭燕燕,孙可淳,麦永嫣,石雪君.子宫内膜癌153例临床分析[J].北京医科大学学报,1994,26(4):261-263. 被引量:3
  • 2彭芝兰.子宫内膜癌的治疗[A].见:曹泽毅主编.中华妇产科学[C].北京:人民卫生出版社,2001.1856. 被引量:1
  • 3Aoki Y,Kase H,Watanabe M,et al. Stage Ⅲ endometrial cancer:analysis of prognostic factors and failure patterns after adjuvant chemotherapy. Gynecol Oncol,2001,83 ( 1 ) : 1. 被引量:1
  • 4Trope C, Kristense GB ,Abeler VM. Clear - cell and papillary serous cancer: treatment options. Best Pract Res Clin Obstet Gynecol,2001,15:433. 被引量:1
  • 5Umasaki N, Tanaka T, Miyana M, et al. Postoperation adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis:a pilot study.Oncol Rep,2000,7(5) :1083. 被引量:1
  • 6Mundt AJ, Murphy KT, Rotmensch J, et al. Surgery and postoperation radiation therapy in FIGO stage Ⅲc endometrial carcinoma. Int J Radiat Oncol Biol Phys,2001,50(5) :1154. 被引量:1
  • 7Fujimura H, Kikkawa F, Oguchi H, et al. Adjuvant chemotherapy including cisplatin in endometrial carcinoma. Gynecol Obstet Invest,2000,50(2) :127. 被引量:1
  • 8Miller DS, Blessing JA, Lentz SS, et al. A phase Ⅱ trial of Topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol, 2002,87:247. 被引量:1
  • 9Silverberg S. Protocol for the examination of specimen from patients with carcinomas of endometrium: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med,1999,123 ( 1 ) :28. 被引量:1
  • 10Cornio G,Lissoni A,Losa G,et al. Brain metastases from endometrial carcinoma. Gynecol Oncol,1996,61:40. 被引量:1

共引文献24

同被引文献33

  • 1李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 2李菲.子宫内膜癌的治疗进展[J].广西医学,2004,26(10):1411-1413. 被引量:3
  • 3Barnes MN,Kilgore LC. Complete surgical staging of ear- ly endometrial adenocarcinoma: optimizing patient out- comes[J]. Semin Radiat Oncol, 2000,10 (1) : 3-7. 被引量:1
  • 4Geisler JP,Wiemann MC, Zhou Z, et al. Using FIGO his- tologic grade to determine when to perform lymphadenee- tomies in endometrioid adenocarcinoma of the endometri- um[J]. Eur J Gynaecol Oncol, 1996,17 (3) : 204-207. 被引量:1
  • 5Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gy- necologic Oncology Group Study[J]. Cancer, 1987, 60 (60) :2035-2041. 被引量:1
  • 6Steiner E, Eicher O. Multivariate independent prognostic factors in endornetrial carcinoma: A clinieopathologic study in 181 patients: 10 years experience at the Depart- ment of Obstetrics and Gynecology of the Mainz Univer- sity[J]. Int J Cancer, 2003,13 (2) : 197-203. 被引量:1
  • 7Mariani A, Webb MJ, Keeney GL, et al. Surgical stage I endometrial cancer:Predictors of distant failure and death [J]. Gynecol Oncol, 2002,87 (3) : 274-280. 被引量:1
  • 8Boren T,Lea J,Kehoe S, et al. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement[J]. Gynecol Oneol, 2012, 127 (1) :43-46. 被引量:1
  • 9Taskin S, Ortac F, Kahraman K, et al. Cervical stromal in- volvement can predict survival in advanced endometrial carcinoma:a review of 67 patients[J]. Int J Clin Oncol, 2013,18(1) : 105-109. 被引量:1
  • 10Kose G,Aka N, Api M. Preoperative assessment of myo- metrial invasion and cervical involvement of endometrial cancer by transvaginal ultrasonography[J]. Gynecol Ob- stet Invest,2003,56(2) : 70-76. 被引量:1

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部